retatrutide peptide obesity triple hormone receptor agonist First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the nejm retatrutide Original Article: Triple–Hormone-Receptor
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13























:max_bytes(150000):strip_icc()/Health-GettyImages-2190382211-1cdb5299c31943bd92857173e09da74e.jpg)





